pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Duke University

updated 5mo ago

Duke University is a private research university in Durham, North Carolina, United States. Founded by Methodists and Quakers in the present-day city of Trinity in 1838, the school moved to Durham in 1892. In 1924, tobacco and electric power industrialist James Buchanan Duke established the Duke Endowment and the institution changed its name to honor his deceased father, Washington Duke.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagImmunology4 co-mentions · 4 sources
  • tagOncology3 co-mentions · 3 sources
  • tagPulmonology2 co-mentions · 2 sources
  • tagAlzheimer's Disease2 co-mentions · 2 sources
  • tagEndocrinology & Metabolism2 co-mentions · 2 sources
  • tagNephrology1 co-mentions · 1 sources
  • tagInfectious Disease1 co-mentions · 1 sources
  • tagCardiology1 co-mentions · 1 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
34
approvals ytd
0
recalls ytd
0

Pipeline(0)

no pipeline products on record

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • N/AImplementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)recruitingn=500
  • phase4Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Interventionrecruitingn=6,000
  • N/AIntracranial Neurophysiological Signatures of Fear and Anxiety in Humansrecruitingn=80
  • phase4Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEPrecruitingn=100
  • —Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)recruitingn=5,000
  • N/APatient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinibnot yet recruitingn=26
  • N/AFast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trialcompletedn=899
  • N/ATest 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?recruitingn=400
🐶 Hiring Signal
No open roles indexed yet — view Duke University jobs →

News

  • Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA
    Two former FDA commissioners: Heidi Overton is the right pick in a difficult moment.
    stat · 12d ago
  • STAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure
    ARPA-H, the government agency that funds cutting edge health research, plans to commit $62.7 million to develop artificial intelligence bots that direct treatment of heart failure.
    stat · 25d ago
  • Lilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro
    With the approval, Eli Lilly’s Mounjaro becomes the first dual GIP/GLP-1 receptor agonist indicated to lower the risk of heart attack, stroke or cardiovascular death in adults with type 2 diabetes.
    biospace · 1mo ago
  • Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate
    Evaxion has scrapped a next-gen solid tumor vaccine in order to channel resources to a candidate specifically targeting brain cancer.
    fiercebiotech · 1mo ago
  • Chutes & Ladders—Biogen R&D vet gets in Formation
    AI-focused Formation Bio has found a new chief scientist with extensive experience in biotech, Big Pharma and academia. Michael Ehlers, M.D., Ph.D., is joining the 2025 Fierce 15 honoree as chief s…
    fiercebiotech · 2mo ago
  • As Maui recovers from devastating fires, a study offers vision for new rural health model
    A study of the long-term health impact of the Lahaina wildfires is inspiring a new model for disaster recovery and support.
    stat · 2mo ago
  • Tiny HHS office tasked with protecting research participants’ safety is running on fumes
    OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effectively protect volunteers.
    stat · 4mo ago
  • Top ultra-processed food researchers call for sweeping policy change: ‘The system is rigged’
    A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.
    stat · 4mo ago
  • Giants of Cancer Care Announces the 14th Annual Class of Inductees
    onclive · 4mo ago
  • Why the FDA is authorizing fruit-flavored vapes
    Marty Makary says he was "skeptical initially" about flavored vapes but that age-gating technology could limit their use.
    stat · 5mo ago
view all news mentions →
identifiers
source
globaldata
mentioned in
10news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?